INS and type 2 diabetes mellitus: Nagao and Yanagita, (2010) [47], reported medium-chain triglycerides (MCTs) and medium-chain fatty acids (MCFAs) have a therapeutic advantage in preserving insulin sensitivity as found in animal models and patients with type 2 diabetes.